Evolus trading resumes

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on EOLS:

• Evolus announces FDA approval of Evolysse products
• Evolus trading halted, news pending
• Evolus price target raised to $22 from $20 at Barclays
• TikTok comes back online in U.S., Schwab reports Q4 beat: Morning Buzz
• Evolus sees FY25 revenue $345M-$355M, consensus $347.37M